Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 24 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Johnny Laupsa-Borge.
K2 Congratulate Camilla Krakstad, Stian Knappskog, Per Eystein Lønning og Bjørn Tore Gjertsen With their grant from The Norwegian Cancer Society.
Read more here
Read more Here
The Diabetes Association awarded “The Diabetes Association’s Research Prize” for the first time, a prize for outstanding diabetes research. Pål received the prize for his research in genetic diabetes variations nationally and internationally. The award took place at the University’s aula in Oslo on the World Diabetes Day. The new research prize from the Diabetes Association has been created to honor, inspire and motivate more diabetes research in Norway.
Read more here (only in Norwegian)
K2 congratulate Pål with the award!
Read more here (Document must be rotated)
Welcome to this years purchaser conference at the University in Bergen
Click here for more info and signup (only in Norwegian)
read more here (only in Norwegian)
Read more here (only in Norwegian)
Guest employes can use the Sammen exercise option.
More information in the Application form found here
If you have concerns you should definitely familiarize yourself with the Health Research Act (Act on medical and health research). This act was approved in 2008 (1 July 2009), and was more recently updated in 2017. Below you will find a short introduction to the act.
§2 defines the aim with medical and health research as research on human beings, human biologic material and health related information. In addition, the act is applicable for pilot studies and exploring treatments. The act also defines the geographical area where research is conducted (in § 3), and relates to Norwegian territory or when research is conducted under the leadership of Norwegian scientists.
§4 involves who is the responsible institution and normally this is the place where the responsible scientist is employed. In addition, we get a definition of the project leader as a person who should have the competence both to topic and science for a responsible performance. The supervisor is normally the project leader and should then have a PhD or corresponding merits.
The project leader has the responsibility for the daily conduct of the project and should oversee: that ethical, health related, scientific and individual concerns are taken; that the institution is informed before the project is started; that applicable ethical approval from REK is at hand; that the project is conducted according to the original plan; as well as appropriate communications to public institutions have been done.
Who must apply at REK? All who conduct research with an aim of novel knowledge about health and disease.
Who does not need to apply? Activities concerned with quality assurance. In addition, there are borderline areas, for example health service research, explorative treatments and methodological developments.
If you have questions/concerns? Use the application template “Remit Assessment”. By this you will get a quick response from REK.
And please note – you will never obtain ethical approval after a project has been started!
How do I apply? You find the Web portal here. There is full electronic handling of applications. The decision is sent to the responsible institution. There are different forms for remit assessment, project application, project amendments, and reports.
If you still have questions and concerns – contact the administration at REK. You find them in the second floor of Armauer Hansen Building.
Roland
Acting Head
K2 is now conducting its annual survey of well-being for all employees.
This is an important part of the HSE work at the institute.
We ask all employees to send their answers via this link.
Thank you!
Postdoc in the Bergen Gynecologic Cancer Research Group, Ingvild Løberg Tangen, was awarded with the best oral presentation prize at the ESGO (European Society of Gynaecological Oncology) congress for the presentation “Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients”. K2 congratulates!
The results are published here.
UiB and Helse Bergen invite to a seminar for female doctors who plan a career in research and academia.
Time: Tuesday 5 December, at. 19:00–20:30.
Venue: Conference room, BB-building.
Program. (Link in Norwegian.)
Deadline for registration: 27 November.